Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Hamilton

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerChau Dang, Neil Iyengar, Farrah Datko, et al.
Nature Medicine|February 28, 2025
Author Correction: Five ways to enhance the diversity and quality of health dataPaola Quattroni, Ash Routen, Joe Alderman, et al.
Nature Medicine|February 24, 2025
Five ways to enhance the diversity and quality of health dataPaola Quattroni, Ash Routen, Joe Alderman, et al.
The Journal of Allergy and Clinical Immunology|May 9, 2021
Prevention and management of allergic reactions to food in child care centers and schools: Practice guidelinesSusan Waserman, Heather Cruickshank, Kyla J Hildebrand, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia CellsStuart Jones, Jonathan Ahmet, Kelly Ayton, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2014
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancerChau Dang, Neil Iyengar, Farrah Datko, et al.
Nature Medicine|February 28, 2025
Author Correction: Five ways to enhance the diversity and quality of health dataPaola Quattroni, Ash Routen, Joe Alderman, et al.
Nature Medicine|February 24, 2025
Five ways to enhance the diversity and quality of health dataPaola Quattroni, Ash Routen, Joe Alderman, et al.
The Journal of Allergy and Clinical Immunology|May 9, 2021
Prevention and management of allergic reactions to food in child care centers and schools: Practice guidelinesSusan Waserman, Heather Cruickshank, Kyla J Hildebrand, et al.
Journal of Medicinal Chemistry|December 23, 2016
Discovery and Optimization of Allosteric Inhibitors of Mutant Isocitrate Dehydrogenase 1 (R132H IDH1) Displaying Activity in Human Acute Myeloid Leukemia CellsStuart Jones, Jonathan Ahmet, Kelly Ayton, et al.
Pageof 2